COMP <GO>
NEPH vs UNH // NET PROFIT MARGIN
Nephros Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: NEPH 5
— UNH 7
▲ NET PROFIT MARGIN LEADER: NEPH
LAST: $3.27 (+3.16%) • MKT CAP: $35.5M
net-margins
6.40%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEPH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEPH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.90% | 88.57% | -26.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.90% | 11.47% | +7.43 | NEPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.3x | 16.4x | +9.85 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.50% | 6.48% | -1.98 | UNH | /fcf-yield <GO> |
| Operating Margin | 6.10% | 4.82% | +1.28 | NEPH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 6.40% | 3.14% | +3.26 | NEPH | /net-margins <GO> |
| Revenue Growth (YoY) | 32.70% | 6.46% | +26.24 | NEPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | NEPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.7 | 59.2 | -22.52 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | 17.1x | +7.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $35.5M | $368.83B | -$368.80B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEPH REV | UNH REV | NEPH GROSS % | UNH GROSS % | NEPH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.8M | $447.57B | 61.9% | 88.7% | $1.6M | $16.07B |
| FY 2024 | $14.2M | $400.28B | 61.6% | 88.3% | -$547.0K | $20.70B |
| FY 2023 | $14.2M | $371.62B | — | 89.6% | $827.0K | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEPH // BETA —
UNH // BETA 0.33